Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03439462
Title ABI-009 (Nab-rapamycin) in Combination With FOLFOX and Bevacizumab as First-line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Aadi, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
Ochsner Clinic Foundation New Orleans Louisiana 70121 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Atlantic Health System/Morristown Medical Center Morristown New Jersey 07962 United States Details
Baylor Scott and White University Medical Center Dallas Texas 75246 United States Details
Seattle Cancer Care Alliance/University of Washington Medical Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field